Literature DB >> 12879103

Ischemic wound healing and possible treatments.

A Quirinia1.   

Abstract

The present review describes the major steps in wound healing, the factors that clinically cause ischemia including the changes found in diabetes mellitus and the possible interventions and treatments of ischemic wounds. The number of randomized, double-blind, controlled clinical trials is scarce, especially on the healing of chronic ischemic soft tissue wounds. Experimental and clinical studies to date have demonstrated that hyperbaric oxygen may be an effective treatment of chronic hypoxic wounds and that certain growth factors (e.g., recombinant platelet-derived growth factor-BB) are likely to enhance the healing of such wounds. Other treatments are discussed, among them vasoactive drugs (e.g., pentoxifylline), occlusive dressings and surgical treatment, including delayed primary closure of acute ischemic wounds.

Entities:  

Year:  2000        PMID: 12879103     DOI: 10.1358/dot.2000.36.1.566626

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  3 in total

Review 1.  A dressing history.

Authors:  Douglas Queen; Heather Orsted; Hiromi Sanada; Geoff Sussman
Journal:  Int Wound J       Date:  2004-04       Impact factor: 3.315

2.  Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds.

Authors:  Sabyasachi Biswas; Sashwati Roy; Jaideep Banerjee; Syed-Rehan A Hussain; Savita Khanna; Guruguhan Meenakshisundaram; Periannan Kuppusamy; Avner Friedman; Chandan K Sen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

3.  Characterization of a preclinical model of chronic ischemic wound.

Authors:  Sashwati Roy; Sabyasachi Biswas; Savita Khanna; Gayle Gordillo; Valerie Bergdall; Jeanne Green; Clay B Marsh; Lisa J Gould; Chandan K Sen
Journal:  Physiol Genomics       Date:  2009-03-17       Impact factor: 3.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.